Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Dreismann Joins AdvanDx Board; ACMG Names Gail Herman as President


AdvanDx said this week that Heiner Dreismann has joined the company's board of directors as an independent director.

Dreismann was an executive at the Roche group from 1985 to 2006, where he held several senior positions, including president and CEO of Roche Molecular Systems. He also served as a member of Roche's Global Diagnostic Executive Committee.

Dreismann currently serves on the board of directors of several public and private healthcare and diagnostic companies, including Myriad Genetics. He holds an MS in biology and PhD in microbiology/molecular biology from the University of Münster in Germany.

Gail Herman has been named the new president of the American College of Medical Genetics and Genomics.

Herman takes over from Wayne Grody, who completed his two-year term at the 2013 Annual Clinical Genetics Meeting in Phoenix, Ariz., in March.

Herman holds a degree in chemistry from Smith College and a PhD in biochemistry and MD from Duke University. She completed residency training in pediatrics and a fellowship in genetics at Baylor College of Medicine, where she later joined the faculty in the Institute for Molecular and Human Genetics as an assistant and then associate professor.

She joined the pediatrics department at Nationwide Children's Hospital and Ohio State University in 1997 and was promoted to professor in 2000. There, she served as director of the division and of the Center for Molecular and Human Genetics from 1998 to 2009.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.